These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14150250)

  • 61. ANTITUMOR ACTIVITY OF GOSSYPOL IN EXPERIMENTS ON TRANSPLANTABLE TUMORS.
    VERMEL EM; KRUGLYAK SA
    Fed Proc Transl Suppl; 1965; 24():106-8. PubMed ID: 14275562
    [No Abstract]   [Full Text] [Related]  

  • 62. [Comparative studies on the antigens of three cytoplasmic fractions from the hepatoma and liver of rats. III. Agar-diffusion test with special reference to the purification of antigens].
    KU KY; WANG JD
    Shi Yan Sheng Wu Xue Bao; 1962 Mar; 7():353-69. PubMed ID: 14460051
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells.
    Qiu MJ; He XX; Bi NR; Wang MM; Xiong ZF; Yang SL
    Clin Chim Acta; 2018 Oct; 485():103-105. PubMed ID: 29940148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CHEMOTHERAPEUTIC STUDIES WITH OSTEOGENIC SARCOMA HE10734.
    MCBRIDE TJ; NOBLE LC; CARR MA; HULL K; OLESON JJ
    Cancer Chemother Rep; 1964 Jan; 34():11-7. PubMed ID: 14116212
    [No Abstract]   [Full Text] [Related]  

  • 65. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. THE SPECIFICITY OF ANTIGENIC PROTEIN OF RAT ASCITES HEPATOMA CELLS.
    HIRAI H; TAGA H; ISAKA H; SATOH H; WARABIOKA K
    Gan; 1963 Jun; 54():177-88. PubMed ID: 14051719
    [No Abstract]   [Full Text] [Related]  

  • 67. [Isolation of specific antigens of transplanted mouse hepatoma by means of an immuno-filtration method].
    ABELEV GI; TSVETKOV VS
    Vopr Onkol; 1960; 6(6)():62-72. PubMed ID: 13791449
    [No Abstract]   [Full Text] [Related]  

  • 68. NEW PROSPECTS IN CANCER BIOCHEMISTRY.
    POTTER VR
    Adv Enzyme Regul; 1963; 1():279-308. PubMed ID: 14190362
    [No Abstract]   [Full Text] [Related]  

  • 69. VENA CAVAGRAMS IN INFANTS AND CHILDREN.
    ALLEN JE; MORSE TS; FRYE TR; CLATWORTHY HW
    Ann Surg; 1964 Oct; 160(4):568-74. PubMed ID: 14210359
    [No Abstract]   [Full Text] [Related]  

  • 70. Hepatoma/merbarone. A Southwest Oncology Group study.
    Poplin EA; Tangen CM; Harvey WH; Macdonald JS
    Invest New Drugs; 1994; 12(4):337-40. PubMed ID: 7775137
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
    Shirahata A; Fan W; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2011 Mar; 31(3):777-80. PubMed ID: 21498695
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medial regression and its functional significance in tumor-supplying host arteries. A morphometric study of hepatic arteries in human livers with hepatocellular carcinoma.
    Suzuki M; Takahashi T; Sato T
    Cancer; 1987 Feb; 59(3):444-50. PubMed ID: 3024804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas.
    De la Revilla NJ; Moreno JM; Rubio E; de Herreros TA; Navarrete E; Lopez MJ; Turrion VS; Jimenez M; Lucena M; Cuervas-Mons V
    Transplant Proc; 2003 Aug; 35(5):1830-1. PubMed ID: 12962812
    [TBL] [Abstract][Full Text] [Related]  

  • 74. EXPERIMENTAL STUDY OF SOME BICYCLIC BIS-(BETA-CHLORETHYL)AMINES.
    KRAVCHENKO AI
    Fed Proc Transl Suppl; 1964; 23():893-5. PubMed ID: 14196960
    [No Abstract]   [Full Text] [Related]  

  • 75. [Photochemical damages to suspended hepatoma carcinoma cells by a new photosensitizer (YWW007)].
    Ye P; Yang CH; Zhang L; Huang Y; Liu J; Wang JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):69-73, 94. PubMed ID: 21355305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transitory liver antigens and primary hepatoma in man and rat.
    Uriel J
    Pathol Biol (Paris); 1969 Oct; 17(19):877-84. PubMed ID: 4314418
    [No Abstract]   [Full Text] [Related]  

  • 77. [The antigenic structure of mouse hepatomas. I. Organ-specific antigens of the liver and immuno-electrophoretic study of their occurrence in hepatomas].
    ABELEV GI; CHRAMKOVA NI; POSTNIKOVA ZA
    Neoplasma; 1962; 9():123-30. PubMed ID: 13858915
    [No Abstract]   [Full Text] [Related]  

  • 78. [ANTINEOPLASTIC ACTIVITY OF SYDNONE IMINES UNDER EXPERIMENTAL CONDITIONS].
    CHERNOV VA; IASHUNSKII VG
    Dokl Akad Nauk SSSR; 1964 Mar; 155():216-9. PubMed ID: 14196214
    [No Abstract]   [Full Text] [Related]  

  • 79. Continuous intra-arterial infusion chemotherapy of hepatoma.
    Sheen MC; Huang TJ; Sheen PC; Ho YH; Sheu HM; Ou SC; Chen CY; Wu CC
    Taiwan Yi Xue Hui Za Zhi; 1983 Mar; 82(3):389-98. PubMed ID: 6193242
    [No Abstract]   [Full Text] [Related]  

  • 80. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
    BLOEDOW CE
    Cancer Chemother Rep; 1964 Aug; 40():39-41. PubMed ID: 14206914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.